Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
US Approves Potential $24.3 Billion F-35 Sale to Saudi Arabia

US Approves Potential $24.3 Billion F-35 Sale to Saudi Arabia

MT newswireMT newswire2026/09/18 09:33
05:33 AM EDT, 09/18/2026 (MT Newswires) -- The US State Department approved a potential $24.3 billion sale of 48 Lockheed Martin (LMT) F-35 fighter jets and related equipment to Saudi Arabia, according to a congressional notification issued Thursday. The package also includes 49 Pratt & Whitney F135 engines, communications and navigation equipment, electronic warfare systems, spare parts, training and logistics services, the agency said. Lockheed Martin and RTX's (RTX) Pratt & Whitney would be the main contractors. The State Department said the sale would support US national security and strengthen Saudi Arabia's ability to respond to current and future threats. The administration said the proposed sale would not change the military balance in the region. It added that the notification represents a proposed sale rather than a completed transaction.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

After Eli Lilly's nearly 300% surge in four years, Wall Street remains bullish: The "hidden pipeline" beyond GLP-1 is underestimated

Eli Lilly’s share price has surged nearly 300% since the approval of its first GLP-1 drug, with its market capitalization surpassing 1 trillion USD, yet Wall Street remains optimistic about its continued growth. Berenberg has upgraded Eli Lilly’s rating to “Buy," believing that Mounjaro and Zepbound will continue to see strong volume, and that the oral GLP-1 drug could further drive demand. Additionally, Eli Lilly continues to expand into areas such as cancer and sleep disorders, and the potential of its non-obesity-related pipelines remains underestimated by the market.

华尔街见闻2026/09/18 13:21